Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management LP, the healthcare-focused investment firm led by activist investor Alex Denner. The SPAC completed its IPO in 2021 targeting opportunities in the biopharmaceutical and life sciences sector, consistent with Sarissa Capital's deep roots in healthcare investing. The January 2022 10-Q/A filing, accession number 0001193125-22-011686, represents an amended quarterly disclosure submitted while the company was still in its target-search phase ahead of any definitive business combination agreement. Sign up at SpacDesk for full filings history, sponsor profiles, and deal-status tracking on SRSA and hundreds of other active SPACs.